2024年6月最新影响因子数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎
反馈给我们。基本信息 | 登录收藏 | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | Drug Design Development and Therapy DRUG DES DEV THER (此期刊被最新的JCR期刊SCIE收录) LetPub评分 6.9
67人评分
我要评分
声誉 7.4 影响力 6.0 速度 9.1 | |||||||||||||||||||||||||||||||
期刊ISSN | 1177-8881 | 微信扫码收藏此期刊 | ||||||||||||||||||||||||||||||
2023-2024最新影响因子 (数据来源于搜索引擎) | 4.7 点击查看影响因子趋势图 | |||||||||||||||||||||||||||||||
实时影响因子 | 截止2024年3月26日:4.659 | |||||||||||||||||||||||||||||||
2023-2024自引率 | 2.10%点击查看自引率趋势图 | |||||||||||||||||||||||||||||||
五年影响因子 | 4.8 | |||||||||||||||||||||||||||||||
JCI期刊引文指标 | 1.1 | |||||||||||||||||||||||||||||||
h-index | 48 | |||||||||||||||||||||||||||||||
CiteScore ( 2024年最新版) |
| |||||||||||||||||||||||||||||||
期刊简介 |
| |||||||||||||||||||||||||||||||
期刊官方网站 | https://www.dovepress.com/drug-design-development-and-therapy-journal | |||||||||||||||||||||||||||||||
期刊投稿网址 | https://www.dovepress.com/submit_step_1.php | |||||||||||||||||||||||||||||||
期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Drug Design Development and Therapy的语言要求,还能让Drug Design Development and Therapy编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Drug Design Development and Therapy编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评(2篇) 论文致谢(2篇) 。
提交文稿 | |||||||||||||||||||||||||||||||
是否OA开放访问 | Yes | |||||||||||||||||||||||||||||||
OA期刊相关信息 | 文章处理费:需要( USD3300; ) 文章处理费豁免:查看说明 其他费用:没有 期刊主题关键词:drug design、drug safety、drug development、pharmaecuticals 相关链接:Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | |||||||||||||||||||||||||||||||
通讯方式 | PO BOX 300-008, ALBANY, NEW ZEALAND, AUCKLAND, 0752 | |||||||||||||||||||||||||||||||
出版商 | Dove Medical Press Ltd. | |||||||||||||||||||||||||||||||
涉及的研究方向 | CHEMISTRY, MEDICINAL-PHARMACOLOGY & PHARMACY | |||||||||||||||||||||||||||||||
出版国家或地区 | ENGLAND | |||||||||||||||||||||||||||||||
出版语言 | English | |||||||||||||||||||||||||||||||
出版周期 | ||||||||||||||||||||||||||||||||
出版年份 | 2007 | |||||||||||||||||||||||||||||||
年文章数 | 256点击查看年文章数趋势图 | |||||||||||||||||||||||||||||||
Gold OA文章占比 | 97.50% | |||||||||||||||||||||||||||||||
研究类文章占比: 文章 ÷(文章 + 综述) | 80.08% | |||||||||||||||||||||||||||||||
WOS期刊SCI分区 ( 2023-2024年最新版) | WOS分区等级:1区
| |||||||||||||||||||||||||||||||
中国科学院《国际期刊预警 名单(试行)》名单 | 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||||||||||||||||
中国科学院SCI期刊分区 ( 2023年12月最新升级版) | 点击查看中国科学院SCI期刊分区趋势图
| |||||||||||||||||||||||||||||||
中国科学院SCI期刊分区 ( 2022年12月升级版) |
| |||||||||||||||||||||||||||||||
中国科学院SCI期刊分区 ( 2021年12月旧的升级版) |
| |||||||||||||||||||||||||||||||
SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) Directory of Open Access Journals (DOAJ) | |||||||||||||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1177-8881%5BISSN%5D | |||||||||||||||||||||||||||||||
平均审稿速度 | 网友分享经验: >12周,或约稿 | |||||||||||||||||||||||||||||||
平均录用比例 | 网友分享经验: | |||||||||||||||||||||||||||||||
版面费/APC文章处理费信息 | 文章处理费:需要( USD3300; ) 文章处理费豁免:查看说明 其他费用:没有 LetPub提供文章处理费(APC)支持服务,可以用人民币支付版面费啦! | |||||||||||||||||||||||||||||||
LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在Drug Design Development and Therapy顺利发表。
快看看作者怎么说吧:服务好评 论文致谢 | |||||||||||||||||||||||||||||||
期刊常用信息链接 |
|
|
|
中国学者近期发表的论文 | |
1. | Binary Nanodrug-Delivery System Designed for Leukemia Therapy: Aptamer- and Transferrin-Codecorated Daunorubicin- and Luteolin-Coloaded Nanoparticles Author: Zhu, Yuanyuan; Zhang, Wei; Chen, Jing Journal: DRUG DESIGN DEVELOPMENT AND THERAPY. 2023; Vol. 17, Issue , pp. 1-13. DOI: 10.2147/DDDT.S387246 PubMed DOI |
2. | Menthone Exerts its Antimicrobial Activity Against Methicillin Resistant Staphylococcus aureus by Affecting Cell Membrane Properties and Lipid Profile Author: Zhao, Wenming; Yang, Chengwei; Zhang, Ning; Peng, Yuanyuan; Ma, Ying; Gu, Keru; Liu, Xia; Liu, Xiaohui; Liu, Xijian; Liu, Yumin; Li, Songkai; Zhao, Linjing Journal: DRUG DESIGN DEVELOPMENT AND THERAPY. 2023; Vol. 17, Issue , pp. 219-236. DOI: 10.2147/DDDT.S384716 PubMed DOI |
3. | Evaluation of Chitosan-Oleuropein Nanoparticles on the Durability of Dentin Bonding Author: Zhao, Shuya; Zhang, Yunyang; Chen, Yun; Xing, Xianghui; Wang, Yu; Wu, Guofeng Journal: DRUG DESIGN DEVELOPMENT AND THERAPY. 2023; Vol. 17, Issue , pp. 167-180. DOI: 10.2147/DDDT.S390039 PubMed DOI |
4. | Efficacy and Mechanism of Qianshan Huoxue Gao in Acute Coronary Syndrome via Regulation of Intestinal Flora and Metabolites Author: Zhao, Ning; Ma, Yan; Liang, Xiaoxue; Zhang, Yu; Hong, Dacheng; Wang, Ying; Bai, Dong Journal: DRUG DESIGN DEVELOPMENT AND THERAPY. 2023; Vol. 17, Issue , pp. 579-595. DOI: 10.2147/DDDT.S396649 PubMed DOI |
5. | Network Pharmacology and Experimental Validation to Explore the Effect and Mechanism of Kanglaite Injection Against Triple-Negative Breast Cancer Author: Zhao, Mei; Fu, Lijuan; Xu, Panling; Wang, Ting; Li, Ping Journal: DRUG DESIGN DEVELOPMENT AND THERAPY. 2023; Vol. 17, Issue , pp. 901-917. DOI: 10.2147/DDDT.S397969 PubMed DOI |
6. | Network Pharmacology and Experimental Validation to Explore That Celastrol Targeting PTEN is the Potential Mechanism of Tripterygium wilfordii (L?v.) Hutch Against IgA Nephropathy Author: Zhao, Juanyong; Liu, Haiyang; Xia, Ming; Chen, Qian; Wan, Lili; Leng, Bin; Tang, Chengyuan; Chen, Guochun; Liu, Yu; Zhang, Lei; Liu, Hong Journal: DRUG DESIGN DEVELOPMENT AND THERAPY. 2023; Vol. 17, Issue , pp. 887-900. DOI: 10.2147/DDDT.S402503 PubMed DOI |
7. | Shensong Yangxin Capsule Reduces the Susceptibility of Arrhythmia in db/db Mice via Inhibiting the Inflammatory Response Induced by Endothelium Dysfunction Author: Zhang, Jiehan; Li, Hongrong; Wang, Dandong; Gu, Jiaojiao; Hou, Yunlong; Wu, Yiling Journal: DRUG DESIGN DEVELOPMENT AND THERAPY. 2023; Vol. 17, Issue , pp. 313-330. DOI: 10.2147/DDDT.S392328 PubMed DOI |
8. | Review on the Diverse Biological Effects of Glabridin Author: Zhang, Jianhong; Wu, Xinhui; Zhong, Baiyin; Liao, Qicheng; Wang, Xin; Xie, Yuankang; He, Xiao Journal: DRUG DESIGN DEVELOPMENT AND THERAPY. 2023; Vol. 17, Issue , pp. 15-37. DOI: 10.2147/DDDT.S385981 PubMed DOI |
9. | Andrographolide Inhibits Static Mechanical Pressure-Induced Intervertebral Disc Degeneration via the MAPK/Nrf2/HO-1 Pathway Author: Zhang, Cunxin; Lu, Ziang; Lyu, Chaoliang; Zhang, Shanshan; Wang, Dechun Journal: DRUG DESIGN DEVELOPMENT AND THERAPY. 2023; Vol. 17, Issue , pp. 535-550. DOI: 10.2147/DDDT.S392535 PubMed DOI |
10. | The Underling Mechanisms Exploration of Rubia cordifolia L. Extract Against Rheumatoid Arthritis by Integrating Network Pharmacology and Metabolomics Author: Zeng, Weiya; Fang, Yuan; Mo, Suifen; Shen, Caihong; Yang, Huiling; Luo, Guihua; Xiao, Luhua; Zhan, Ruoting; Yan, Ping Journal: DRUG DESIGN DEVELOPMENT AND THERAPY. 2023; Vol. 17, Issue , pp. 439-457. DOI: 10.2147/DDDT.S388932 PubMed DOI |
|
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2024 中国: LetPub上海 网站备案号:沪ICP备10217908号-1 沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)
增值电信业务经营许可证:沪B2-20211595 网络文化经营许可证:沪网文[2023]2004-152号
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室